Drug resistance continues to be a major problem in the effective treatment of many diseases. Resistance to chemotherapy, whether intrinsic or extrinsic, is the result of at least three well defined mechanisms:: prevention of the interaction of drug with the target, decreased intracellular concentration of the drug due to an increased efflux or a decreased influx, and enzymatic modification or destruction of the drug. With the advancement in technology, the molecular mechanisms of drug resistance have been unravelling at a rapid rate. This book is a timely review of such advances in drug resistance research. The nine chapters of this book, written by a group of clinicians and scientists, elegantly summarises recent advances in our understanding of this important clinical problem with emphasis on cisplatin, fibroblasts, natural compounds, erythropoiesis-stimulating agents, prostate cancer and kidney cancer. This book will be an important contribution to science, and an invaluable tool for researchers who are interested in drug resistance.
Mechanisms of Cisplatin Resistance:: DNA Repair & Cellular Implications; Multi-Drug Resistance in Cancer & New Approaches for its Overcoming; Tumor Fibroblasts:: Pivotal Players in Drug Resistance; Erythropoiesis Stimulating Agent Resistance; Therapeutic Options for Metastatic Castration Resistant Prostate Cancer:: Has the Situation Improved?; Current Trends in Prostate Cancer Treatment & Drug Resistance; Resistance of Metastatic Renal Cell Carcinomas to Chemo & Immunotherapy:: Clinicians Perspective; Resistance of Renal Cell Carcinoma to Targeted Therapy; Molecular Mechanisms of Sunitinib Resistance in Renal Cell Carcinoma.
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.